Sapir Alex Insider Trades

Insider Trading History

Track insider trading activity for Sapir Alex. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
See Remarks
Holding Value $2.19M 650,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.97M 650,000 shares
$10.72
$3.37
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
See Remarks
Holding Value $1.96M 582,000 shares
Last Trade
Jan 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42M 582,000 shares
$4.16
$3.37
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
See Remarks
Holding Value $652k 193,360 shares
Last Trade
Jul 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$924k 150,000 shares
$6.16
$3.37
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
See Remarks
Holding Value $7.68M 2,280,400 shares
Last Trade
Jul 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$924k 150,000 shares
$6.16
$3.37
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
See Remarks
Holding Value $146k 43,360 shares
Last Trade
Mar 04, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$492k 43,360 shares
$11.35
$3.37
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
See Remarks
Holding Value $0 0 shares
Last Trade
Jul 01, 2023 Sale
$7.95M 2,430,400 shares
$3.27
$3.37
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $0 0 shares
Last Trade
May 19, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $263 3,750 shares
Last Trade
May 19, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $1.23k 17,500 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.9k 21,250 shares
$0.84
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $981 14,000 shares
Last Trade
Jun 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.4k 14,000 shares
$3.53
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $344 4,909 shares
Last Trade
Jun 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.9k 4,909 shares
$4.86
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $2.24k 32,000 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 32,000 shares
$5.19
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up